- The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Boston Scientific ( NYSE: BSX ) LithoVue Elite Single-Use Digital Flexible Ureteroscope System.
- The company said the device is the first ureteroscope system which monitors intrarenal pressure in real-time during ureteroscopy procedures.
- Ureteroscopy is a procedure to diagnose issues in the urinary tract, most commonly kidney stones.
- "We designed the next-generation LithoVue Elite System to bring a greater level of precision and functionality in the way urologists diagnose and treat kidney stones, an increasingly common condition among adults," said Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, Boston Scientific.
For further details see:
Boston Scientific LithoVue Elite system for kidney stones diagnosis gets FDA clearance